2022 Q4 Form 10-Q Financial Statement

#000185648522000038 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $927.0M $968.0M $908.0M
YoY Change -4.63% 6.61% 23.04%
Cost Of Revenue $654.0M $687.0M $587.0M
YoY Change -1.06% 17.04% 17.4%
Gross Profit $273.0M $281.0M $321.0M
YoY Change -12.22% -12.46% 34.87%
Gross Profit Margin 29.45% 29.03% 35.35%
Selling, General & Admin $103.0M $80.00M $47.00M
YoY Change -35.22% 70.21% -6.0%
% of Gross Profit 37.73% 28.47% 14.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $31.00M $30.00M $37.00M
YoY Change -11.43% -18.92% -2.63%
% of Gross Profit 11.36% 10.68% 11.53%
Operating Expenses $134.0M $80.00M $47.00M
YoY Change -30.93% 70.21% -6.0%
Operating Profit $139.0M $201.0M $274.0M
YoY Change 18.8% -26.64% 45.74%
Interest Expense -$17.00M $21.00M -$10.00M
YoY Change 0.0% -310.0% -600.0%
% of Operating Profit -12.23% 10.45% -3.65%
Other Income/Expense, Net
YoY Change
Pretax Income $122.0M $147.0M $120.0M
YoY Change 22.0% 22.5% 90.48%
Income Tax $34.00M $38.00M $28.00M
% Of Pretax Income 27.87% 25.85% 23.33%
Net Earnings $94.00M $57.00M $92.00M
YoY Change 51.61% -38.04% 80.39%
Net Earnings / Revenue 10.14% 5.89% 10.13%
Basic Earnings Per Share $1.29 $2.09
Diluted Earnings Per Share $2.08 $1.28 $2.086M
COMMON SHARES
Basic Shares Outstanding 44.13M shares 44.13M shares 44.10M shares
Diluted Shares Outstanding 44.60M shares 44.10M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $360.0M $163.0M $132.0M
YoY Change 100.0% 23.48%
Cash & Equivalents $360.0M $163.0M $132.0M
Short-Term Investments $80.00M $86.00M $7.000M
Other Short-Term Assets $39.00M $21.00M $96.00M
YoY Change -38.1% -78.13%
Inventory $364.0M $338.0M $344.0M
Prepaid Expenses
Receivables $430.0M $458.0M $401.0M
Other Receivables $20.00M $24.00M $21.00M
Total Short-Term Assets $1.243B $1.409B $1.019B
YoY Change 12.18% 38.27%
LONG-TERM ASSETS
Property, Plant & Equipment $1.174B $1.095B $1.239B
YoY Change -2.49% -11.62%
Goodwill $128.0M $124.0M $136.0M
YoY Change 4.92% -8.82%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $158.0M $161.0M $334.0M
YoY Change 9.72% -51.8%
Total Long-Term Assets $1.467B $1.388B $1.718B
YoY Change -1.48% -19.21%
TOTAL ASSETS
Total Short-Term Assets $1.243B $1.409B $1.019B
Total Long-Term Assets $1.467B $1.388B $1.718B
Total Assets $2.710B $2.797B $2.737B
YoY Change 4.35% 2.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $453.0M $396.0M $315.0M
YoY Change 17.05% 25.71%
Accrued Expenses $94.00M $70.00M $89.00M
YoY Change 40.3% -21.35%
Deferred Revenue $0.00 $1.000M $8.000M
YoY Change -100.0% -87.5%
Short-Term Debt $26.00M $0.00 $124.0M
YoY Change -31.58% -100.0%
Long-Term Debt Due $29.00M $29.00M $24.00M
YoY Change 52.63% 20.83%
Total Short-Term Liabilities $728.0M $1.029B $784.0M
YoY Change -3.96% 31.25%
LONG-TERM LIABILITIES
Long-Term Debt $1.003B $1.200B $1.393B
YoY Change -26.14% -13.85%
Other Long-Term Liabilities $118.0M $129.0M $132.0M
YoY Change 0.0% -2.27%
Total Long-Term Liabilities $118.0M $129.0M $132.0M
YoY Change 0.0% -2.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $728.0M $1.029B $784.0M
Total Long-Term Liabilities $118.0M $129.0M $132.0M
Total Liabilities $846.0M $1.158B $916.0M
YoY Change -3.42% 26.42%
SHAREHOLDERS EQUITY
Retained Earnings $2.029B $1.949B
YoY Change 4.86%
Common Stock $44.00M $44.00M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 1.600M shares
Shareholders Equity $678.0M $258.0M $265.0M
YoY Change
Total Liabilities & Shareholders Equity $2.710B $2.797B $2.737B
YoY Change 4.35% 2.19%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $94.00M $57.00M $92.00M
YoY Change 51.61% -38.04% 80.39%
Depreciation, Depletion And Amortization $31.00M $30.00M $37.00M
YoY Change -11.43% -18.92% -2.63%
Cash From Operating Activities $204.0M $143.0M $170.0M
YoY Change 20.0% -15.88% 132.88%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $276.0M -$32.00M $178.0M
YoY Change -2223.08% -117.98% -784.62%
Cash From Investing Activities $276.0M -$32.00M $178.0M
YoY Change -2223.08% -117.98% -784.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -288.0M -90.00M -383.0M
YoY Change 41.87% -76.5% 1220.69%
NET CHANGE
Cash From Operating Activities 204.0M 143.0M 170.0M
Cash From Investing Activities 276.0M -32.00M 178.0M
Cash From Financing Activities -288.0M -90.00M -383.0M
Net Change In Cash 192.0M 21.00M -35.00M
YoY Change -517.39% -160.0% -294.44%
FREE CASH FLOW
Cash From Operating Activities $204.0M $143.0M $170.0M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001856485
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022Q3 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2021Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2021Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q3 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations
CY2021Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40718
dei Entity Registrant Name
EntityRegistrantName
SYLVAMO CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2596371
dei Entity Address Address Line1
EntityAddressAddressLine1
6077 Primacy Parkway
dei Entity Address City Or Town
EntityAddressCityOrTown
Memphis
dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
38119
dei City Area Code
CityAreaCode
901
dei Local Phone Number
LocalPhoneNumber
519-8000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44128521 shares
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
968000000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
731000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2701000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2050000000 usd
CY2022Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
687000000 usd
CY2021Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
556000000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1965000000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1540000000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
80000000 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
46000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
227000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
142000000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30000000 usd
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
94000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
95000000 usd
CY2022Q3 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
6000000 usd
CY2021Q4 syl Debt Instrument Number Of Term Loans
DebtInstrumentNumberOfTermLoans
2 term_loan
CY2021Q3 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
8000000 usd
us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
18000000 usd
us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
21000000 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-18000000 usd
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-10000000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-52000000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
19000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
147000000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
78000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
345000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
271000000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
97000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
109000000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
59000000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
248000000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
198000000 usd
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-52000000 usd
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
33000000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-224000000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
71000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
57000000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
92000000 usd
us-gaap Net Income Loss
NetIncomeLoss
24000000 usd
us-gaap Net Income Loss
NetIncomeLoss
269000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.47
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.34
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
5.62
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
4.50
CY2022Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-1.18
CY2021Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.75
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-5.08
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
1.60
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.29
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.10
us-gaap Interest Paid Net
InterestPaidNet
1000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.44
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.34
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
5.58
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.50
CY2022Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-1.16
CY2021Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.75
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-5.04
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
1.60
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.28
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.10
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
57000000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
92000000 usd
us-gaap Net Income Loss
NetIncomeLoss
24000000 usd
us-gaap Net Income Loss
NetIncomeLoss
269000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Benefit Plan Improvement Tax Effect
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
0 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Benefit Plan Improvement Tax Effect
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
0 usd
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Benefit Plan Improvement Tax Effect
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
0 usd
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Benefit Plan Improvement Tax Effect
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
0 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
0 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
0 usd
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
1000000 usd
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
0 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-57000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-100000000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
21000000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-115000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
-2000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
2000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
-15000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
1000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
7000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-5000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
40000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-1000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
1000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
-1000000 usd
CY2022Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
482000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
6000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
1000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
2000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-1000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
12000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
1000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-52000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-104000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
48000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-117000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5000000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
72000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
152000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
163000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
159000000 usd
CY2021Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
402000000 usd
CY2022Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
28000000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
26000000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
338000000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
279000000 usd
CY2022Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
377000000 usd
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
179000000 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
21000000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
63000000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1409000000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1108000000 usd
CY2022Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
753000000 usd
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
764000000 usd
CY2022Q3 syl Forestlands
Forestlands
303000000 usd
CY2021Q4 syl Forestlands
Forestlands
278000000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
8000000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
124000000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
122000000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
39000000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
40000000 usd
CY2022Q3 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
0 usd
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
141000000 usd
CY2022Q3 syl Deferred Costs And Other Assets Noncurrent
DeferredCostsAndOtherAssetsNoncurrent
169000000 usd
CY2021Q4 syl Deferred Costs And Other Assets Noncurrent
DeferredCostsAndOtherAssetsNoncurrent
144000000 usd
CY2022Q3 us-gaap Assets
Assets
2797000000 usd
CY2021Q4 us-gaap Assets
Assets
2597000000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
396000000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
387000000 usd
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
29000000 usd
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
41000000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
56000000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
48000000 usd
CY2022Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
365000000 usd
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
91000000 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
183000000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
191000000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1029000000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
758000000 usd
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1200000000 usd
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1357000000 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
181000000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
169000000 usd
CY2022Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
0 usd
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
13000000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
129000000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
118000000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000.0 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000.0 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44100000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44100000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43900000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43900000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
44000000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
44000000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
20000000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4000000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1949000000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1935000000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1753000000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1801000000 usd
CY2022Q3 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
260000000 usd
CY2021Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
182000000 usd
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
100000 shares
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0.0 shares
CY2022Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
2000000 usd
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
258000000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
182000000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2797000000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2597000000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
248000000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
198000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
94000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
95000000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-4000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
16000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
10000000 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
81000000 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
37000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
76000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9000000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
18000000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
97000000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-53000000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
54000000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
276000000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
292000000 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
20000000 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
87000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
296000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
379000000 usd
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
91000000 usd
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
47000000 usd
syl Proceeds From Cash Pool Arrangement With Parent Investing Activities
ProceedsFromCashPoolArrangementWithParentInvestingActivities
0 usd
syl Proceeds From Cash Pool Arrangement With Parent Investing Activities
ProceedsFromCashPoolArrangementWithParentInvestingActivities
181000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
8000000 usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-91000000 usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
126000000 usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-5000000 usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
14000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-96000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
140000000 usd
syl Net Transfer From To Parent Financing Activities
NetTransferFromToParentFinancingActivities
0 usd
syl Net Transfer From To Parent Financing Activities
NetTransferFromToParentFinancingActivities
-359000000 usd
syl Payments To Parent Financing Activities
PaymentsToParentFinancingActivities
0 usd
syl Payments To Parent Financing Activities
PaymentsToParentFinancingActivities
1520000000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
5000000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
0 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1499000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
174000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-181000000 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-385000000 usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-1000000 usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-1000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-182000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-386000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-96000000 usd
syl Cash Included In Held For Sale Increase Decrease
CashIncludedInHeldForSaleIncreaseDecrease
41000000 usd
syl Cash Included In Held For Sale Increase Decrease
CashIncludedInHeldForSaleIncreaseDecrease
-17000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
54000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159000000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
163000000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
124000000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35000000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
120000000 usd
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
1500000000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
968000000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
731000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2701000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2050000000 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1000000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1000000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
252000000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6000000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1125
CY2022Q3 us-gaap Dividends Common Stock
DividendsCommonStock
5000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5000000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
258000000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
182000000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14000000 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.2250
us-gaap Dividends Common Stock
DividendsCommonStock
10000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
72000000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
258000000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2284000000 usd
CY2021Q3 syl Stockholders Equity Transfers From To Parent
StockholdersEquityTransfersFromToParent
-487000000 usd
CY2021Q3 syl Stockholders Equity Special Payment To Parent
StockholdersEquitySpecialPaymentToParent
-1520000000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12000000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
265000000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2112000000 usd
syl Stockholders Equity Transfers From To Parent
StockholdersEquityTransfersFromToParent
-479000000 usd
syl Stockholders Equity Special Payment To Parent
StockholdersEquitySpecialPaymentToParent
-1520000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
152000000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
265000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
109000000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
59000000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
248000000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
198000000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44100000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43900000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44100000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43900000 shares
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
500000 shares
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
400000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
86000000 usd
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44600000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43900000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43900000 shares
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.47
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.34
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
5.62
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
4.50
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.44
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.34
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
5.58
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.50
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
64000000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
458000000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
391000000 usd
CY2022Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
24000000 usd
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
11000000 usd
CY2022Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
482000000 usd
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
402000000 usd
CY2022Q3 syl Receivables Allowance For Credit Loss Current
ReceivablesAllowanceForCreditLossCurrent
20000000 usd
CY2021Q4 syl Receivables Allowance For Credit Loss Current
ReceivablesAllowanceForCreditLossCurrent
19000000 usd
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
35000000 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
37000000 usd
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
215000000 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
164000000 usd
CY2022Q3 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
74000000 usd
CY2021Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
69000000 usd
CY2022Q3 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
14000000 usd
CY2021Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
9000000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
338000000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
279000000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3500000000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3500000000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
30000000 usd
CY2021Q3 us-gaap Depreciation
Depreciation
33000000 usd
us-gaap Depreciation
Depreciation
94000000 usd
us-gaap Depreciation
Depreciation
95000000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
11000000 usd
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6000000 usd
us-gaap Interest Paid Net
InterestPaidNet
55000000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
21000000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
12000000 usd
us-gaap Interest Expense
InterestExpense
59000000 usd
us-gaap Interest Expense
InterestExpense
13000000 usd
CY2022Q3 us-gaap Interest Income Operating
InterestIncomeOperating
2000000 usd
CY2021Q3 us-gaap Interest Income Operating
InterestIncomeOperating
2000000 usd
us-gaap Interest Income Operating
InterestIncomeOperating
5000000 usd
us-gaap Interest Income Operating
InterestIncomeOperating
32000000 usd
CY2022Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1000000 usd
CY2021Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
2000000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0 usd
CY2022Q3 syl Interest Expense Income Including Capitalized Interest Costs Net
InterestExpenseIncomeIncludingCapitalizedInterestCostsNet
18000000 usd
CY2021Q3 syl Interest Expense Income Including Capitalized Interest Costs Net
InterestExpenseIncomeIncludingCapitalizedInterestCostsNet
10000000 usd
syl Interest Expense Income Including Capitalized Interest Costs Net
InterestExpenseIncomeIncludingCapitalizedInterestCostsNet
52000000 usd
syl Interest Expense Income Including Capitalized Interest Costs Net
InterestExpenseIncomeIncludingCapitalizedInterestCostsNet
-19000000 usd
CY2021Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
26000000 usd
CY2022Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
26000000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
15000000 usd
CY2021Q3 us-gaap Lease Cost
LeaseCost
11000000 usd
us-gaap Lease Cost
LeaseCost
45000000 usd
us-gaap Lease Cost
LeaseCost
28000000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
39000000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
40000000 usd
CY2022Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
24000000 usd
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
27000000 usd
CY2022Q3 syl Lease Right Of Use Asset
LeaseRightOfUseAsset
63000000 usd
CY2021Q4 syl Lease Right Of Use Asset
LeaseRightOfUseAsset
67000000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14000000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
15000000 usd
CY2022Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2000000 usd
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
3000000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30000000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
25000000 usd
CY2022Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
15000000 usd
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
17000000 usd
CY2022Q3 syl Lease Liability
LeaseLiability
61000000 usd
CY2021Q4 syl Lease Liability
LeaseLiability
60000000 usd
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
12000000 usd
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
9000000 usd
CY2021Q4 us-gaap Goodwill Gross
GoodwillGross
123000000 usd
CY2021Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
1000000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
122000000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
2000000 usd
CY2022Q3 us-gaap Goodwill Gross
GoodwillGross
125000000 usd
CY2022Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
1000000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
124000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
97000000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
63000000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
55000000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8000000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
63000000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
54000000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9000000 usd
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000000 usd
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.26
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.28
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73000000 usd
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.24
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.27
us-gaap Income Tax Examination Estimate Of Possible Loss
IncomeTaxExaminationEstimateOfPossibleLoss
109000000 usd
us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
346000000 usd
CY2022Q3 syl Income Tax Examination Tax Liability Percentage Threshold One
IncomeTaxExaminationTaxLiabilityPercentageThresholdOne
0.40
CY2022Q3 syl Income Tax Examination Maximum Tax Liability Threshold One
IncomeTaxExaminationMaximumTaxLiabilityThresholdOne
300000000 usd
CY2022Q3 syl Income Tax Examination Maximum Tax Liability Threshold One
IncomeTaxExaminationMaximumTaxLiabilityThresholdOne
300000000 usd
CY2022Q3 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
21000000 usd
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
29000000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
19000000 usd
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1200000000 usd
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1357000000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5000000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10000000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
19000000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y4M24D
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
968000000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
731000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2701000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2050000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
147000000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
78000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
345000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
271000000 usd

Files In Submission

Name View Source Status
0001856485-22-000038-index-headers.html Edgar Link pending
0001856485-22-000038-index.html Edgar Link pending
0001856485-22-000038.txt Edgar Link pending
0001856485-22-000038-xbrl.zip Edgar Link pending
exhibit104-sylvamoxamend.htm Edgar Link pending
exhibit104-sylvamoxamend001.jpg Edgar Link pending
exhibit104-sylvamoxamend002.jpg Edgar Link pending
exhibit104-sylvamoxamend003.jpg Edgar Link pending
exhibit104-sylvamoxamend004.jpg Edgar Link pending
exhibit104-sylvamoxamend005.jpg Edgar Link pending
exhibit104-sylvamoxamend006.jpg Edgar Link pending
exhibit104-sylvamoxamend007.jpg Edgar Link pending
exhibit104-sylvamoxamend008.jpg Edgar Link pending
exhibit104-sylvamoxamend009.jpg Edgar Link pending
exhibit104-sylvamoxamend010.jpg Edgar Link pending
exhibit104-sylvamoxamend011.jpg Edgar Link pending
exhibit104-sylvamoxamend012.jpg Edgar Link pending
exhibit104-sylvamoxamend013.jpg Edgar Link pending
exhibit104-sylvamoxamend014.jpg Edgar Link pending
exhibit104-sylvamoxamend015.jpg Edgar Link pending
exhibit104-sylvamoxamend016.jpg Edgar Link pending
exhibit104-sylvamoxamend017.jpg Edgar Link pending
exhibit104-sylvamoxamend018.jpg Edgar Link pending
exhibit104-sylvamoxamend019.jpg Edgar Link pending
exhibit104-sylvamoxamend020.jpg Edgar Link pending
exhibit104-sylvamoxamend021.jpg Edgar Link pending
exhibit104-sylvamoxamend022.jpg Edgar Link pending
exhibit104-sylvamoxamend023.jpg Edgar Link pending
exhibit104-sylvamoxamend024.jpg Edgar Link pending
exhibit104-sylvamoxamend025.jpg Edgar Link pending
exhibit104-sylvamoxamend026.jpg Edgar Link pending
exhibit104-sylvamoxamend027.jpg Edgar Link pending
exhibit104-sylvamoxamend028.jpg Edgar Link pending
exhibit104-sylvamoxamend029.jpg Edgar Link pending
exhibit104-sylvamoxamend030.jpg Edgar Link pending
exhibit104-sylvamoxamend031.jpg Edgar Link pending
exhibit104-sylvamoxamend032.jpg Edgar Link pending
exhibit104-sylvamoxamend033.jpg Edgar Link pending
exhibit104-sylvamoxamend034.jpg Edgar Link pending
exhibit104-sylvamoxamend035.jpg Edgar Link pending
exhibit104-sylvamoxamend036.jpg Edgar Link pending
exhibit104-sylvamoxamend037.jpg Edgar Link pending
exhibit104-sylvamoxamend038.jpg Edgar Link pending
exhibit104-sylvamoxamend039.jpg Edgar Link pending
exhibit104-sylvamoxamend040.jpg Edgar Link pending
exhibit104-sylvamoxamend041.jpg Edgar Link pending
exhibit104-sylvamoxamend042.jpg Edgar Link pending
exhibit104-sylvamoxamend043.jpg Edgar Link pending
exhibit104-sylvamoxamend044.jpg Edgar Link pending
exhibit104-sylvamoxamend045.jpg Edgar Link pending
exhibit104-sylvamoxamend046.jpg Edgar Link pending
exhibit104-sylvamoxamend047.jpg Edgar Link pending
exhibit104-sylvamoxamend048.jpg Edgar Link pending
exhibit104-sylvamoxamend049.jpg Edgar Link pending
exhibit104-sylvamoxamend050.jpg Edgar Link pending
exhibit104-sylvamoxamend051.jpg Edgar Link pending
exhibit104-sylvamoxamend052.jpg Edgar Link pending
exhibit104-sylvamoxamend053.jpg Edgar Link pending
exhibit104-sylvamoxamend054.jpg Edgar Link pending
exhibit104-sylvamoxamend055.jpg Edgar Link pending
exhibit104-sylvamoxamend056.jpg Edgar Link pending
exhibit104-sylvamoxamend057.jpg Edgar Link pending
exhibit104-sylvamoxamend058.jpg Edgar Link pending
exhibit104-sylvamoxamend059.jpg Edgar Link pending
exhibit104-sylvamoxamend060.jpg Edgar Link pending
exhibit104-sylvamoxamend061.jpg Edgar Link pending
exhibit104-sylvamoxamend062.jpg Edgar Link pending
exhibit104-sylvamoxamend063.jpg Edgar Link pending
exhibit104-sylvamoxamend064.jpg Edgar Link pending
exhibit104-sylvamoxamend065.jpg Edgar Link pending
exhibit104-sylvamoxamend066.jpg Edgar Link pending
exhibit104-sylvamoxamend067.jpg Edgar Link pending
exhibit104-sylvamoxamend068.jpg Edgar Link pending
exhibit104-sylvamoxamend069.jpg Edgar Link pending
exhibit104-sylvamoxamend070.jpg Edgar Link pending
exhibit104-sylvamoxamend071.jpg Edgar Link pending
exhibit104-sylvamoxamend072.jpg Edgar Link pending
exhibit104-sylvamoxamend073.jpg Edgar Link pending
exhibit104-sylvamoxamend074.jpg Edgar Link pending
exhibit104-sylvamoxamend075.jpg Edgar Link pending
exhibit104-sylvamoxamend076.jpg Edgar Link pending
exhibit104-sylvamoxamend077.jpg Edgar Link pending
exhibit104-sylvamoxamend078.jpg Edgar Link pending
exhibit104-sylvamoxamend079.jpg Edgar Link pending
exhibit104-sylvamoxamend080.jpg Edgar Link pending
exhibit104-sylvamoxamend081.jpg Edgar Link pending
exhibit104-sylvamoxamend082.jpg Edgar Link pending
exhibit104-sylvamoxamend083.jpg Edgar Link pending
exhibit104-sylvamoxamend084.jpg Edgar Link pending
exhibit104-sylvamoxamend085.jpg Edgar Link pending
exhibit104-sylvamoxamend086.jpg Edgar Link pending
exhibit104-sylvamoxamend087.jpg Edgar Link pending
exhibit104-sylvamoxamend088.jpg Edgar Link pending
exhibit104-sylvamoxamend089.jpg Edgar Link pending
exhibit104-sylvamoxamend090.jpg Edgar Link pending
exhibit104-sylvamoxamend091.jpg Edgar Link pending
exhibit104-sylvamoxamend092.jpg Edgar Link pending
exhibit104-sylvamoxamend093.jpg Edgar Link pending
exhibit104-sylvamoxamend094.jpg Edgar Link pending
exhibit104-sylvamoxamend095.jpg Edgar Link pending
exhibit104-sylvamoxamend096.jpg Edgar Link pending
exhibit104-sylvamoxamend097.jpg Edgar Link pending
exhibit104-sylvamoxamend098.jpg Edgar Link pending
exhibit104-sylvamoxamend099.jpg Edgar Link pending
exhibit104-sylvamoxamend100.jpg Edgar Link pending
exhibit104-sylvamoxamend101.jpg Edgar Link pending
exhibit104-sylvamoxamend102.jpg Edgar Link pending
exhibit104-sylvamoxamend103.jpg Edgar Link pending
exhibit104-sylvamoxamend104.jpg Edgar Link pending
exhibit104-sylvamoxamend105.jpg Edgar Link pending
exhibit104-sylvamoxamend106.jpg Edgar Link pending
exhibit104-sylvamoxamend107.jpg Edgar Link pending
exhibit104-sylvamoxamend108.jpg Edgar Link pending
exhibit104-sylvamoxamend109.jpg Edgar Link pending
exhibit104-sylvamoxamend110.jpg Edgar Link pending
exhibit104-sylvamoxamend111.jpg Edgar Link pending
exhibit104-sylvamoxamend112.jpg Edgar Link pending
exhibit104-sylvamoxamend113.jpg Edgar Link pending
exhibit104-sylvamoxamend114.jpg Edgar Link pending
exhibit104-sylvamoxamend115.jpg Edgar Link pending
exhibit104-sylvamoxamend116.jpg Edgar Link pending
exhibit104-sylvamoxamend117.jpg Edgar Link pending
exhibit104-sylvamoxamend118.jpg Edgar Link pending
exhibit104-sylvamoxamend119.jpg Edgar Link pending
exhibit104-sylvamoxamend120.jpg Edgar Link pending
exhibit104-sylvamoxamend121.jpg Edgar Link pending
exhibit104-sylvamoxamend122.jpg Edgar Link pending
exhibit104-sylvamoxamend123.jpg Edgar Link pending
exhibit104-sylvamoxamend124.jpg Edgar Link pending
exhibit104-sylvamoxamend125.jpg Edgar Link pending
exhibit104-sylvamoxamend126.jpg Edgar Link pending
exhibit104-sylvamoxamend127.jpg Edgar Link pending
exhibit104-sylvamoxamend128.jpg Edgar Link pending
exhibit104-sylvamoxamend129.jpg Edgar Link pending
exhibit104-sylvamoxamend130.jpg Edgar Link pending
exhibit104-sylvamoxamend131.jpg Edgar Link pending
exhibit104-sylvamoxamend132.jpg Edgar Link pending
exhibit104-sylvamoxamend133.jpg Edgar Link pending
exhibit104-sylvamoxamend134.jpg Edgar Link pending
exhibit104-sylvamoxamend135.jpg Edgar Link pending
exhibit104-sylvamoxamend136.jpg Edgar Link pending
exhibit104-sylvamoxamend137.jpg Edgar Link pending
exhibit104-sylvamoxamend138.jpg Edgar Link pending
exhibit104-sylvamoxamend139.jpg Edgar Link pending
exhibit104-sylvamoxamend140.jpg Edgar Link pending
exhibit104-sylvamoxamend141.jpg Edgar Link pending
exhibit104-sylvamoxamend142.jpg Edgar Link pending
exhibit104-sylvamoxamend143.jpg Edgar Link pending
exhibit104-sylvamoxamend144.jpg Edgar Link pending
exhibit104-sylvamoxamend145.jpg Edgar Link pending
exhibit104-sylvamoxamend146.jpg Edgar Link pending
exhibit104-sylvamoxamend147.jpg Edgar Link pending
exhibit104-sylvamoxamend148.jpg Edgar Link pending
exhibit104-sylvamoxamend149.jpg Edgar Link pending
exhibit104-sylvamoxamend150.jpg Edgar Link pending
exhibit104-sylvamoxamend151.jpg Edgar Link pending
exhibit104-sylvamoxamend152.jpg Edgar Link pending
exhibit104-sylvamoxamend153.jpg Edgar Link pending
exhibit104-sylvamoxamend154.jpg Edgar Link pending
exhibit104-sylvamoxamend155.jpg Edgar Link pending
exhibit104-sylvamoxamend156.jpg Edgar Link pending
exhibit104-sylvamoxamend157.jpg Edgar Link pending
exhibit104-sylvamoxamend158.jpg Edgar Link pending
exhibit104-sylvamoxamend159.jpg Edgar Link pending
exhibit104-sylvamoxamend160.jpg Edgar Link pending
exhibit104-sylvamoxamend161.jpg Edgar Link pending
exhibit104-sylvamoxamend162.jpg Edgar Link pending
exhibit104-sylvamoxamend163.jpg Edgar Link pending
exhibit104-sylvamoxamend164.jpg Edgar Link pending
exhibit104-sylvamoxamend165.jpg Edgar Link pending
exhibit104-sylvamoxamend166.jpg Edgar Link pending
exhibit104-sylvamoxamend167.jpg Edgar Link pending
exhibit104-sylvamoxamend168.jpg Edgar Link pending
exhibit104-sylvamoxamend169.jpg Edgar Link pending
exhibit104-sylvamoxamend170.jpg Edgar Link pending
exhibit104-sylvamoxamend171.jpg Edgar Link pending
exhibit104-sylvamoxamend172.jpg Edgar Link pending
exhibit104-sylvamoxamend173.jpg Edgar Link pending
exhibit104-sylvamoxamend174.jpg Edgar Link pending
exhibit104-sylvamoxamend175.jpg Edgar Link pending
exhibit104-sylvamoxamend176.jpg Edgar Link pending
exhibit104-sylvamoxamend177.jpg Edgar Link pending
exhibit104-sylvamoxamend178.jpg Edgar Link pending
exhibit104-sylvamoxamend179.jpg Edgar Link pending
exhibit104-sylvamoxamend180.jpg Edgar Link pending
exhibit104-sylvamoxamend181.jpg Edgar Link pending
exhibit104-sylvamoxamend182.jpg Edgar Link pending
exhibit104-sylvamoxamend183.jpg Edgar Link pending
exhibit104-sylvamoxamend184.jpg Edgar Link pending
exhibit104-sylvamoxamend185.jpg Edgar Link pending
exhibit104-sylvamoxamend186.jpg Edgar Link pending
exhibit104-sylvamoxamend187.jpg Edgar Link pending
exhibit104-sylvamoxamend188.jpg Edgar Link pending
exhibit104-sylvamoxamend189.jpg Edgar Link pending
exhibit104-sylvamoxamend190.jpg Edgar Link pending
exhibit104-sylvamoxamend191.jpg Edgar Link pending
exhibit104-sylvamoxamend192.jpg Edgar Link pending
exhibit104-sylvamoxamend193.jpg Edgar Link pending
exhibit104-sylvamoxamend194.jpg Edgar Link pending
exhibit104-sylvamoxamend195.jpg Edgar Link pending
exhibit104-sylvamoxamend196.jpg Edgar Link pending
exhibit104-sylvamoxamend197.jpg Edgar Link pending
exhibit104-sylvamoxamend198.jpg Edgar Link pending
exhibit104-sylvamoxamend199.jpg Edgar Link pending
exhibit104-sylvamoxamend200.jpg Edgar Link pending
exhibit104-sylvamoxamend201.jpg Edgar Link pending
exhibit104-sylvamoxamend202.jpg Edgar Link pending
exhibit104-sylvamoxamend203.jpg Edgar Link pending
exhibit104-sylvamoxamend204.jpg Edgar Link pending
exhibit104-sylvamoxamend205.jpg Edgar Link pending
exhibit104-sylvamoxamend206.jpg Edgar Link pending
exhibit104-sylvamoxamend207.jpg Edgar Link pending
exhibit104-sylvamoxamend208.jpg Edgar Link pending
exhibit104-sylvamoxamend209.jpg Edgar Link pending
exhibit104-sylvamoxamend210.jpg Edgar Link pending
exhibit104-sylvamoxamend211.jpg Edgar Link pending
exhibit104-sylvamoxamend212.jpg Edgar Link pending
exhibit104-sylvamoxamend213.jpg Edgar Link pending
exhibit104-sylvamoxamend214.jpg Edgar Link pending
exhibit104-sylvamoxamend215.jpg Edgar Link pending
exhibit104-sylvamoxamend216.jpg Edgar Link pending
exhibit104-sylvamoxamend217.jpg Edgar Link pending
exhibit104-sylvamoxamend218.jpg Edgar Link pending
exhibit104-sylvamoxamend219.jpg Edgar Link pending
exhibit104-sylvamoxamend220.jpg Edgar Link pending
exhibit104-sylvamoxamend221.jpg Edgar Link pending
exhibit104-sylvamoxamend222.jpg Edgar Link pending
exhibit104-sylvamoxamend223.jpg Edgar Link pending
exhibit104-sylvamoxamend224.jpg Edgar Link pending
exhibit104-sylvamoxamend225.jpg Edgar Link pending
exhibit104-sylvamoxamend226.jpg Edgar Link pending
exhibit104-sylvamoxamend227.jpg Edgar Link pending
exhibit104-sylvamoxamend228.jpg Edgar Link pending
exhibit104-sylvamoxamend229.jpg Edgar Link pending
exhibit104-sylvamoxamend230.jpg Edgar Link pending
exhibit104-sylvamoxamend231.jpg Edgar Link pending
exhibit104-sylvamoxamend232.jpg Edgar Link pending
exhibit104-sylvamoxamend233.jpg Edgar Link pending
exhibit104-sylvamoxamend234.jpg Edgar Link pending
exhibit104-sylvamoxamend235.jpg Edgar Link pending
exhibit104-sylvamoxamend236.jpg Edgar Link pending
exhibit104-sylvamoxamend237.jpg Edgar Link pending
exhibit104-sylvamoxamend238.jpg Edgar Link pending
exhibit104-sylvamoxamend239.jpg Edgar Link pending
exhibit104-sylvamoxamend240.jpg Edgar Link pending
exhibit104-sylvamoxamend241.jpg Edgar Link pending
exhibit104-sylvamoxamend242.jpg Edgar Link pending
exhibit104-sylvamoxamend243.jpg Edgar Link pending
exhibit104-sylvamoxamend244.jpg Edgar Link pending
exhibit104-sylvamoxamend245.jpg Edgar Link pending
exhibit104-sylvamoxamend246.jpg Edgar Link pending
exhibit104-sylvamoxamend247.jpg Edgar Link pending
exhibit104-sylvamoxamend248.jpg Edgar Link pending
exhibit104-sylvamoxamend249.jpg Edgar Link pending
exhibit104-sylvamoxamend250.jpg Edgar Link pending
exhibit104-sylvamoxamend251.jpg Edgar Link pending
exhibit104-sylvamoxamend252.jpg Edgar Link pending
exhibit104-sylvamoxamend253.jpg Edgar Link pending
exhibit104-sylvamoxamend254.jpg Edgar Link pending
exhibit104-sylvamoxamend255.jpg Edgar Link pending
exhibit104-sylvamoxamend256.jpg Edgar Link pending
exhibit104-sylvamoxamend257.jpg Edgar Link pending
exhibit104-sylvamoxamend258.jpg Edgar Link pending
exhibit104-sylvamoxamend259.jpg Edgar Link pending
exhibit104-sylvamoxamend260.jpg Edgar Link pending
exhibit104-sylvamoxamend261.jpg Edgar Link pending
exhibit104-sylvamoxamend262.jpg Edgar Link pending
exhibit104-sylvamoxamend263.jpg Edgar Link pending
exhibit104-sylvamoxamend264.jpg Edgar Link pending
exhibit104-sylvamoxamend265.jpg Edgar Link pending
exhibit104-sylvamoxamend266.jpg Edgar Link pending
exhibit104-sylvamoxamend267.jpg Edgar Link pending
exhibit104-sylvamoxamend268.jpg Edgar Link pending
exhibit104-sylvamoxamend269.jpg Edgar Link pending
exhibit104-sylvamoxamend270.jpg Edgar Link pending
exhibit104-sylvamoxamend271.jpg Edgar Link pending
exhibit104-sylvamoxamend272.jpg Edgar Link pending
exhibit104-sylvamoxamend273.jpg Edgar Link pending
exhibit104-sylvamoxamend274.jpg Edgar Link pending
exhibit104-sylvamoxamend275.jpg Edgar Link pending
exhibit104-sylvamoxamend276.jpg Edgar Link pending
exhibit104-sylvamoxamend277.jpg Edgar Link pending
exhibit104-sylvamoxamend278.jpg Edgar Link pending
exhibit104-sylvamoxamend279.jpg Edgar Link pending
exhibit104-sylvamoxamend280.jpg Edgar Link pending
exhibit104-sylvamoxamend281.jpg Edgar Link pending
exhibit104-sylvamoxamend282.jpg Edgar Link pending
exhibit104-sylvamoxamend283.jpg Edgar Link pending
exhibit104-sylvamoxamend284.jpg Edgar Link pending
exhibit104-sylvamoxamend285.jpg Edgar Link pending
exhibit104-sylvamoxamend286.jpg Edgar Link pending
exhibit104-sylvamoxamend287.jpg Edgar Link pending
exhibit104-sylvamoxamend288.jpg Edgar Link pending
exhibit104-sylvamoxamend289.jpg Edgar Link pending
exhibit104-sylvamoxamend290.jpg Edgar Link pending
exhibit104-sylvamoxamend291.jpg Edgar Link pending
exhibit104-sylvamoxamend292.jpg Edgar Link pending
exhibit104-sylvamoxamend293.jpg Edgar Link pending
exhibit104-sylvamoxamend294.jpg Edgar Link pending
exhibit104-sylvamoxamend295.jpg Edgar Link pending
exhibit104-sylvamoxamend296.jpg Edgar Link pending
exhibit104-sylvamoxamend297.jpg Edgar Link pending
exhibit104-sylvamoxamend298.jpg Edgar Link pending
exhibit104-sylvamoxamend299.jpg Edgar Link pending
exhibit104-sylvamoxamend300.jpg Edgar Link pending
exhibit104-sylvamoxamend301.jpg Edgar Link pending
exhibit104-sylvamoxamend302.jpg Edgar Link pending
exhibit104-sylvamoxamend303.jpg Edgar Link pending
exhibit104-sylvamoxamend304.jpg Edgar Link pending
exhibit104-sylvamoxamend305.jpg Edgar Link pending
exhibit104-sylvamoxamend306.jpg Edgar Link pending
exhibit104-sylvamoxamend307.jpg Edgar Link pending
exhibit104-sylvamoxamend308.jpg Edgar Link pending
exhibit104-sylvamoxamend309.jpg Edgar Link pending
exhibit104-sylvamoxamend310.jpg Edgar Link pending
exhibit104-sylvamoxamend311.jpg Edgar Link pending
exhibit104-sylvamoxamend312.jpg Edgar Link pending
exhibit104-sylvamoxamend313.jpg Edgar Link pending
exhibit104-sylvamoxamend314.jpg Edgar Link pending
exhibit104-sylvamoxamend315.jpg Edgar Link pending
exhibit104-sylvamoxamend316.jpg Edgar Link pending
exhibit104-sylvamoxamend317.jpg Edgar Link pending
exhibit104-sylvamoxamend318.jpg Edgar Link pending
exhibit104-sylvamoxamend319.jpg Edgar Link pending
exhibit104-sylvamoxamend320.jpg Edgar Link pending
exhibit104-sylvamoxamend321.jpg Edgar Link pending
exhibit104-sylvamoxamend322.jpg Edgar Link pending
exhibit104-sylvamoxamend323.jpg Edgar Link pending
exhibit104-sylvamoxamend324.jpg Edgar Link pending
exhibit104-sylvamoxamend325.jpg Edgar Link pending
exhibit104-sylvamoxamend326.jpg Edgar Link pending
exhibit104-sylvamoxamend327.jpg Edgar Link pending
exhibit104-sylvamoxamend328.jpg Edgar Link pending
exhibit104-sylvamoxamend329.jpg Edgar Link pending
exhibit104-sylvamoxamend330.jpg Edgar Link pending
exhibit104-sylvamoxamend331.jpg Edgar Link pending
exhibit104-sylvamoxamend332.jpg Edgar Link pending
exhibit104-sylvamoxamend333.jpg Edgar Link pending
exhibit104-sylvamoxamend334.jpg Edgar Link pending
exhibit104-sylvamoxamend335.jpg Edgar Link pending
exhibit104-sylvamoxamend336.jpg Edgar Link pending
exhibit104-sylvamoxamend337.jpg Edgar Link pending
exhibit104-sylvamoxamend338.jpg Edgar Link pending
exhibit104-sylvamoxamend339.jpg Edgar Link pending
exhibit104-sylvamoxamend340.jpg Edgar Link pending
exhibit104-sylvamoxamend341.jpg Edgar Link pending
exhibit104-sylvamoxamend342.jpg Edgar Link pending
exhibit104-sylvamoxamend343.jpg Edgar Link pending
exhibit104-sylvamoxamend344.jpg Edgar Link pending
exhibit104-sylvamoxamend345.jpg Edgar Link pending
exhibit104-sylvamoxamend346.jpg Edgar Link pending
exhibit104-sylvamoxamend347.jpg Edgar Link pending
exhibit104-sylvamoxamend348.jpg Edgar Link pending
exhibit104-sylvamoxamend349.jpg Edgar Link pending
exhibit104-sylvamoxamend350.jpg Edgar Link pending
exhibit104-sylvamoxamend351.jpg Edgar Link pending
exhibit104-sylvamoxamend352.jpg Edgar Link pending
exhibit104-sylvamoxamend353.jpg Edgar Link pending
exhibit104-sylvamoxamend354.jpg Edgar Link pending
exhibit104-sylvamoxamend355.jpg Edgar Link pending
exhibit104-sylvamoxamend356.jpg Edgar Link pending
exhibit104-sylvamoxamend357.jpg Edgar Link pending
exhibit104-sylvamoxamend358.jpg Edgar Link pending
exhibit104-sylvamoxamend359.jpg Edgar Link pending
exhibit104-sylvamoxamend360.jpg Edgar Link pending
exhibit104-sylvamoxamend361.jpg Edgar Link pending
exhibit104-sylvamoxamend362.jpg Edgar Link pending
exhibit104-sylvamoxamend363.jpg Edgar Link pending
exhibit104-sylvamoxamend364.jpg Edgar Link pending
exhibit104-sylvamoxamend365.jpg Edgar Link pending
exhibit104-sylvamoxamend366.jpg Edgar Link pending
exhibit104-sylvamoxamend367.jpg Edgar Link pending
exhibit104-sylvamoxamend368.jpg Edgar Link pending
exhibit104-sylvamoxamend369.jpg Edgar Link pending
exhibit104-sylvamoxamend370.jpg Edgar Link pending
exhibit104-sylvamoxamend371.jpg Edgar Link pending
exhibit104-sylvamoxamend372.jpg Edgar Link pending
exhibit104-sylvamoxamend373.jpg Edgar Link pending
exhibit104-sylvamoxamend374.jpg Edgar Link pending
exhibit104-sylvamoxamend375.jpg Edgar Link pending
exhibit104-sylvamoxamend376.jpg Edgar Link pending
exhibit104-sylvamoxamend377.jpg Edgar Link pending
exhibit104-sylvamoxamend378.jpg Edgar Link pending
exhibit104-sylvamoxamend379.jpg Edgar Link pending
exhibit104-sylvamoxamend380.jpg Edgar Link pending
exhibit104-sylvamoxamend381.jpg Edgar Link pending
exhibit104-sylvamoxamend382.jpg Edgar Link pending
exhibit104-sylvamoxamend383.jpg Edgar Link pending
exhibit104-sylvamoxamend384.jpg Edgar Link pending
exhibit104-sylvamoxamend385.jpg Edgar Link pending
exhibit104-sylvamoxamend386.jpg Edgar Link pending
exhibit104-sylvamoxamend387.jpg Edgar Link pending
exhibit104-sylvamoxamend388.jpg Edgar Link pending
exhibit104-sylvamoxamend389.jpg Edgar Link pending
exhibit104-sylvamoxamend390.jpg Edgar Link pending
exhibit104-sylvamoxamend391.jpg Edgar Link pending
exhibit104-sylvamoxamend392.jpg Edgar Link pending
exhibit104-sylvamoxamend393.jpg Edgar Link pending
exhibit104-sylvamoxamend394.jpg Edgar Link pending
exhibit104-sylvamoxamend395.jpg Edgar Link pending
exhibit104-sylvamoxamend396.jpg Edgar Link pending
exhibit104-sylvamoxamend397.jpg Edgar Link pending
exhibit104-sylvamoxamend398.jpg Edgar Link pending
exhibit104-sylvamoxamend399.jpg Edgar Link pending
exhibit104-sylvamoxamend400.jpg Edgar Link pending
exhibit104-sylvamoxamend401.jpg Edgar Link pending
exhibit104-sylvamoxamend402.jpg Edgar Link pending
exhibit104-sylvamoxamend403.jpg Edgar Link pending
exhibit104-sylvamoxamend404.jpg Edgar Link pending
exhibit104-sylvamoxamend405.jpg Edgar Link pending
exhibit104-sylvamoxamend406.jpg Edgar Link pending
exhibit104-sylvamoxamend407.jpg Edgar Link pending
exhibit104-sylvamoxamend408.jpg Edgar Link pending
exhibit104-sylvamoxamend409.jpg Edgar Link pending
exhibit104-sylvamoxamend410.jpg Edgar Link pending
exhibit104-sylvamoxamend411.jpg Edgar Link pending
exhibit104-sylvamoxamend412.jpg Edgar Link pending
exhibit104-sylvamoxamend413.jpg Edgar Link pending
exhibit104-sylvamoxamend414.jpg Edgar Link pending
exhibit104-sylvamoxamend415.jpg Edgar Link pending
exhibit104-sylvamoxamend416.jpg Edgar Link pending
exhibit104-sylvamoxamend417.jpg Edgar Link pending
exhibit104-sylvamoxamend418.jpg Edgar Link pending
exhibit104-sylvamoxamend419.jpg Edgar Link pending
exhibit104-sylvamoxamend420.jpg Edgar Link pending
exhibit104-sylvamoxamend421.jpg Edgar Link pending
exhibit104-sylvamoxamend422.jpg Edgar Link pending
exhibit104-sylvamoxamend423.jpg Edgar Link pending
exhibit104-sylvamoxamend424.jpg Edgar Link pending
exhibit104-sylvamoxamend425.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
syl-20220930.htm Edgar Link pending
syl-20220930.xsd Edgar Link pending
syl-20220930_g1.jpg Edgar Link pending
syl-20220930_g2.jpg Edgar Link pending
sylvamoex3112022q3.htm Edgar Link pending
sylvamoex3122022q3.htm Edgar Link pending
sylvamoex322022q3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
syl-20220930_def.xml Edgar Link unprocessable
syl-20220930_lab.xml Edgar Link unprocessable
syl-20220930_cal.xml Edgar Link unprocessable
syl-20220930_pre.xml Edgar Link unprocessable
syl-20220930_htm.xml Edgar Link completed